Yield10 Bioscience (NASDAQ:YTEN – Get Free Report) and Green Thumb Industries (OTC:GTBIF – Get Free Report) are both small-cap consumer staples companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation.
Valuation and Earnings
This table compares Yield10 Bioscience and Green Thumb Industries”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Yield10 Bioscience | $60,000.00 | 0.18 | -$14.45 million | ($26.12) | 0.00 |
| Green Thumb Industries | $1.05 billion | 0.99 | $36.27 million | $0.21 | 23.43 |
Insider and Institutional Ownership
4.9% of Yield10 Bioscience shares are held by institutional investors. Comparatively, 0.1% of Green Thumb Industries shares are held by institutional investors. 6.1% of Yield10 Bioscience shares are held by company insiders. Comparatively, 9.4% of Green Thumb Industries shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Analyst Ratings
This is a breakdown of recent ratings and target prices for Yield10 Bioscience and Green Thumb Industries, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Yield10 Bioscience | 0 | 0 | 0 | 0 | 0.00 |
| Green Thumb Industries | 0 | 0 | 0 | 3 | 4.00 |
Risk and Volatility
Yield10 Bioscience has a beta of 1.48, suggesting that its stock price is 48% more volatile than the S&P 500. Comparatively, Green Thumb Industries has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500.
Profitability
This table compares Yield10 Bioscience and Green Thumb Industries’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Yield10 Bioscience | N/A | N/A | -296.08% |
| Green Thumb Industries | 5.68% | 3.65% | 2.52% |
Summary
Green Thumb Industries beats Yield10 Bioscience on 11 of the 13 factors compared between the two stocks.
About Yield10 Bioscience
Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.
About Green Thumb Industries
Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RHYTHM brands. It distributes its products primarily to third-party retail customers and sells finished products directly to consumers in its own retail stores, as well as direct-to consumer delivery channel. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.
Receive News & Ratings for Yield10 Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yield10 Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
